Searching…
U.S. POINTER is a lifestyle intervention clinical trial to support brain health, improve cognition & speed progress in Alzheimer's and dementia research.
Results from the U.S. POINTER clinical trial found that two lifestyle interventions targeting a combination of physical activity, improving nutrition, cognitive and social challenge, and health monitoring improved cog...
U.S. POINTER is a clinical trial to evaluate whether lifestyle interventions that simultaneously target multiple risk factors protect cognitive function in older adults (age 60-79) at increased risk for cognitive decline.
U.S. POINTER is the first large-scale clinical trial to show that healthy lifestyle behaviors targeting multiple risk factors can protect cognitive function.
The Alzheimer's Association is providing funding for the U.S. POINTER study, with local offices assisting in intervention delivery. Learn more.
TORONTO, July 28, 2025 — The Alzheimer's Association U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER) — a two-year, multi-site clinical trial testing two different lifest...
The Alzheimer’s Association U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER) — a two-year, multi-site clinical trial testing two different lifestyle interventions in a re...
While the cognitive health of all participants in U.S. POINTER improved, the group* that followed a more structured program improved even more, helping to protect thinking and memory from the normal decline that often...
The U.S. POINTER neuroimaging ancillary study is the first large-scale investigation of how lifestyle interventions – including exercise, diet, cognitive stimulation and health coaching – affect biological markers of ...
The Alzheimer's Association U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER) is a two-year clinical trial to evaluate whether lifestyle interventions that target many ris...
